Position in LLY
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$29,535,966
+$7,260,057 QoQ
Shares Held
24,625
+1.7% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
1.32%
of 13F equity value
Holder Rank
#727
of 4,605 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026KCM INVESTMENT ADVISORS LLC holds $142,663,499 across 11 Drug Manufacturers - General names. LLY ranks #3 (20.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
187,862 | $47,711,312 | |
| 2 | AMGN |
Amgen Inc
|
87,850 | $31,812,242 | |
| 3 | LLY |
ELI LILLY & Co
This page
|
24,625 | $29,535,966 | |
| 4 | ABBV |
AbbVie Inc.
|
76,198 | $19,174,464 | |
| 5 | MRK |
Merck & Co., Inc.
|
53,356 | $6,856,246 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
21,638 | $2,733,744 | |
| 7 | NVS |
Novartis AG
|
9,075 | $1,422,234 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
22,865 | $1,317,481 |
All Filings in LLY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $29,535,966 | 24,625 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $22,275,909 | 24,219 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $26,894,944 | 25,026 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $19,026,168 | 24,936 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $17,053,777 | 21,877 | Shares | Sole | 2025-08-06 | |
| 2025-03-31 | $31,178,102 | 37,750 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $28,887,468 | 37,419 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $34,257,527 | 38,668 | Shares | Sole | 2024-11-06 | |
| 2024-06-30 | $34,652,514 | 38,274 | Shares | Sole | 2024-07-29 | |
| 2024-03-31 | $29,711,070 | 38,191 | Shares | Sole | 2024-05-07 | |
| 2023-12-31 | $22,286,197 | 38,232 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $19,488,150 | 36,282 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $15,210,897 | 32,434 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $8,748,281 | 25,474 | Shares | Sole | 2023-05-09 | |
| 2022-12-31 | $8,378,101 | 22,901 | Shares | Sole | 2023-01-31 | |
| 2022-09-30 | $7,397,924 | 22,879 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $7,418,382 | 22,880 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $6,971,391 | 24,344 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $6,814,347 | 24,670 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $5,748,292 | 24,879 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $5,736,852 | 24,995 | Shares | Sole | 2021-10-21 | |
| 2021-03-31 | $4,757,371 | 25,465 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $4,172,880 | 24,715 | Shares | Sole | 2021-02-19 | |
| 2020-09-30 | $3,186,722 | 21,529 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $4,095,305 | 24,944 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $3,395,449 | 24,477 | Shares | Sole | 2020-04-27 | |
| No filing history on record for this holder in this stock. | ||||||